Bristol Myers: EMA submission for colorectal cancer

Bristol Myers Squibb announces that the European Medicines Agency has validated its application for Opdivo + Yervoy as first-line treatment for adult patients with metastatic colorectal cancer with...

Related Keywords

Bristol Myers Squibb ,Dana Walker ,European Medicines Agency ,Global Head ,Genitourinary Cancers ,Bristol Myers ,Markets ,